Author： Spencer Benjamin WJ Prainsack Barbara Rujescu Dan Giegling Ina Collier David A Gaughran Fiona MacCabe James H Barr Cathy L Sigurdsson Engilbert Stovring Henrik Malhotra Anil K Curran Sarah R
Publisher： Future Medicine
ISSN： 1462-2416
Source： Pharmacogenomics, Vol.14, Iss.15, 2013-11, pp. : 1907-1914
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Targeting MAPK Signalling: Prometheus' Fire or Pandora's Box?
Current Pharmaceutical Design, Vol. 10, Iss. 16, 2004-06 ,pp. :
Access to resources
Recommend
A Peek into Pandora's Box: The Medical Excuse Marijuana Controversy
By Voth Eric A.
Journal of Addictive Diseases, Vol. 22, Iss. 4, 2003-12 ,pp. :
Starting Clozapine in the Community: A UK Perspective
CNS Drugs, Vol. 18, Iss. 13, 2004-01 ,pp. :
FDA clears Third Wave pharmacogenetic test
Pharmacogenomics, Vol. 6, Iss. 7, 2005-10 ,pp. :
European Journal of Pharmacology, Vol. 463, Iss. 1, 2003-02 ,pp. :